EGFR-TKI for Advanced NSCLC Market

EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutations.
EGFR-TKI for Advanced NSCLC Market aims to provide a comprehensive presentation of the global market for EGFR-TKI for Advanced NSCLC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EGFR-TKI for Advanced NSCLC. EGFR-TKI for Advanced NSCLC Market contains market size and forecasts of EGFR-TKI for Advanced NSCLC in global, including the following market information:
Global EGFR-TKI for Advanced NSCLC Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global EGFR-TKI for Advanced NSCLC market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Gefitinib Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of EGFR-TKI for Advanced NSCLC include Henan DaKen Chemical, Capot Chemical Co.,Ltd., Chemwill Asia Co.,Ltd., MSN Labs, Sun Pharma, Amadis Chemical, Chongqing Chemdad Co., Ltd, Mylan and Alchem Pharmtech,Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the EGFR-TKI for Advanced NSCLC companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global EGFR-TKI for Advanced NSCLC Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global EGFR-TKI for Advanced NSCLC Market Segment Percentages, by Type, 2022 (%)
Gefitinib
Erlotinib
Afatinib
Global EGFR-TKI for Advanced NSCLC Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global EGFR-TKI for Advanced NSCLC Market Segment Percentages, by Application, 2022 (%)
Combination Therapy
Mono Therapy
Global EGFR-TKI for Advanced NSCLC Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global EGFR-TKI for Advanced NSCLC Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies EGFR-TKI for Advanced NSCLC revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies EGFR-TKI for Advanced NSCLC revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Henan DaKen Chemical
Capot Chemical Co.,Ltd.
Chemwill Asia Co.,Ltd.
MSN Labs
Sun Pharma
Amadis Chemical
Chongqing Chemdad Co., Ltd
Mylan
Alchem Pharmtech,Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of EGFR-TKI for Advanced NSCLC, market overview.
Chapter 2: Global EGFR-TKI for Advanced NSCLC market size in revenue.
Chapter 3: Detailed analysis of EGFR-TKI for Advanced NSCLC company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of EGFR-TKI for Advanced NSCLC in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.